Nuvation Bio Inc. (NYSE: NUVB), a global oncology company tackling some of the toughest challenges in cancer treatment, today ...

Nuvation Bio (NUVB) delivered earnings and revenue surprises of 0.00% and +93.32%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference call and webcast on ...

FDA approval of IBTROZI (taletrectinib) transformed Nuvation Bio into a commercial-stage company, driving $4.8 million in GAAP revenue, well above GAAP revenue estimates. Earnings per share (GAAP) was ...

Nuvation Bio Inc. (NYSE:NUVB) is one of the penny stocks that will skyrocket. On June 24, the company confirmed the addition of its Taletrectinib (IBTROZI) treatment as a Preferred Agent in the ...

NEW YORK--(BUSINESS WIRE)-- Nuvation Bio Inc. (NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced it will host a conference ...

Nuvation Bio Inc. (NYSE: NUVB), a global oncology company focused on tackling some of the toughest challenges in cancer treatment, today announced that new data will be presented at the IASLC 2025 ...

To get a sense of who is truly in control of Nuvation Bio Inc. , it is important to understand the ownership structure of the business. And the group that holds the biggest piece ...

Nuvation Bio Inc. (NYSE: NUVB) is one of the penny stocks that will skyrocket. On June 24, the company confirmed the addition of its Taletrectinib (IBTROZI) treatment as a Preferred Agent in the ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Aclaris Therapeutics (ACRS – Research Report) and Nuvation Bio (NUVB – Research Report) with ...

Baystreet.ca News Commentary – In the United States, federal budget cuts threaten to slow the nation’s progress in the fight against cancer, but the private sector appears ...